News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Amanda Nerstad Shares Experience as Participant in ALK Vaccine Trial for Lung Cancer
Amanda Nerstad/LinkedIn
May 10, 2025, 09:59

Amanda Nerstad Shares Experience as Participant in ALK Vaccine Trial for Lung Cancer

Amanda Nerstad, Lung Cancer Survivor and Advocate, posted on LinkedIn:

“Thank you to Roche for sharing my story — I’m honored to be patient 2 in the ALK vaccine trial. Grateful for the progress in ALK-positive lung cancer.”

Amanda Nerstad expressed appreciation to Roche for amplifying her story as the second participant in the ALK vaccine trial. She highlighted ongoing progress in the treatment of ALK-positive lung cancer and her advocacy as a survivor.

Read Further.

More posts featuring Lung Cancer.

ALK vaccine trial Amanda Nerstad cancer Lung cancer OncoDaily Oncology Roche
Special Coverage
Blog
Jun 3, 2025, 10:56
Giannis Mountzios: ASCO25 is About Science, Research, Care but Also Your Second Family - Colleagues and Friends
Blog
Jun 3, 2025, 10:50
Paolo Tarantino: We need Biomarkers to Tailor Treatment with T-DXd
Opinion
Jun 3, 2025, 10:41
TRIgnite-1 study at ASCO 2025 showed High Response Rates and Favorable Safety Profile for the Treatment of Relapsed/Refractory Multiple Myeloma with First-in-Class BCMA × CD38 × CD3 Trispecific Antibody 
Blog
Jun 3, 2025, 10:35
Mario Balsa Shares ASCENT-04 Trial Results in First-Line mTNBC at ASCO25
Blog
Jun 3, 2025, 10:33
Vivek Subbiah: Waiting for ASCO 2025 Hematology Discussions with Naveen Pemmaraju
Blog
Jun 3, 2025, 10:27
Supriya Peshin Reflects on a Memorable Moment with Oncology Colleagues
Blog
Jun 3, 2025, 09:54
Robin Zon: ASCO 2025 President’s Address - “Driving Knowledge to Action: Building a Better Future”
Science
Jun 3, 2025, 09:52
Breaking research on GLP-1s and cancer from ASCO 2025
Blog
Jun 3, 2025, 09:48
Rami Manochakian: Results of ALNEO Phase 2 Trial at ASCO25
Blog
Jun 3, 2025, 09:33
Sagal Pannu: Tarlatamab and Emerging Bispecific T-cell Engagers Changing the Treatment Landscape of SCLC
Blog
Jun 3, 2025, 09:25
Nehemias Guevara-Rodriguez: Honored to Meet Saad Z. Usmani a Giant in Cancer Care
Blog
Jun 3, 2025, 09:15
Harold J. Burstein: First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer